KROS
#3577
Keros Therapeutics, Inc. - common stock
11.1 0 USD
-0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.93%
Monthly Change
+7.25%
6 month change
-42.93%
Year Change
-26.49%
Previous Close
11.8 0
Open
11.1 0
Low
11.1 0
High
11.1 0
Volume
44
Financials
- Market Capitalization 219.69 M
- Employee 87
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
8.85
Price to sales ratio
3.16
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3571 |  DTIL Precision BioSciences, Inc. - Common Stock | 8.59 USD | -1.94% | +4.76% | +39.00% | +86.74% | 221.64 M USD | ||
| 3575 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 8.93 USD | -7.37% | -5.40% | +4.20% | +114.66% | 220.72 M USD | ||
| 3580 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.35 USD | -1.36% | 0.00% | +2.84% | -46.49% | 219.12 M USD | ||
| 3583 |  AVXL Anavex Life Sciences Corp. - Common Stock | 2.35 USD | -6.00% | -12.64% | -7.84% | -79.39% | 217.78 M USD |
Frequently asked questions about Keros Therapeutics, Inc. - common stock
What is the Keros Therapeutics, Inc. - common stock stock price today?
The current price of Keros Therapeutics, Inc. - common stock (KROS) is 11.1. Over the past 24 hours, the stock has changed by -5.93%. Follow the KROS chart for real-time price dynamics.
What is the stock ticker of Keros Therapeutics, Inc. - common stock?
Keros Therapeutics, Inc. - common stock trades under the ticker KROS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Keros Therapeutics, Inc. - common stock stock going up?
KROS has changed by +0.36% over the last week, +7.25% over the last month, and -26.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Keros Therapeutics, Inc. - common stock net income for the last quarter?
Keros Therapeutics, Inc. - common stock reported net income of -23.71 M for the last quarter. The previous quarter showed -23.46 M, which means net income changed by -1.05%.
How many employees does Keros Therapeutics, Inc. - common stock have?
As of the latest available data, Keros Therapeutics, Inc. - common stock has 87 employees. Workforce size can provide additional context about the company's scale and operations.
What is Keros Therapeutics, Inc. - common stock EBITDA?
Keros Therapeutics, Inc. - common stock EBITDA is -25.81 M, and its EBITDA margin is -80.65 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Keros Therapeutics, Inc. - common stock stock?
You can buy Keros Therapeutics, Inc. - common stock (KROS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Keros Therapeutics, Inc. - common stock stock?
Investing in Keros Therapeutics, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KROS chart and related analysis on metatrader.com as part of your research.